Influence of the National Hospital Pharmaceutical Strategy on the Assessment of New Medicines in New Zealand Public Hospitals

Publisher： John Wiley & Sons Inc

E-ISSN： 2055-2335|35|4|271-275

ISSN： 1445-937x

Source： JOURNAL OF PHARMACY PRACTICE AND RESEARCH, Vol.35, Iss.4, 2005-12, pp. : 271-275

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Processes for the Assessment and Introduction of New Medicines in New Zealand Hospitals

By  

JOURNAL OF PHARMACY PRACTICE AND RESEARCH, Vol. 34, Iss. 4, 2004-12 ,pp. : 267-271

John Wiley & Sons Inc

Access to resources Recommend Favorite

Pharmaceutical Expenditure and Therapeutic Value of New Medicines in Spain

By Darba J.  

PharmacoEconomics, Vol. 21, Iss. 16, 2003-01 ,pp. : 1211-1212

Adis International

Access to resources Recommend Favorite

Standardizing the Benefit-Risk Assessment of New Medicines: Practical Applications of Frameworks for the Pharmaceutical Healthcare Professional

By Liberti Lawrence   >   Walker Stuart  

Pharmaceutical Medicine, Vol. 25, Iss. 3, 2011-06 ,pp. : 139-146

Adis International

Access to resources Recommend Favorite

Activities to promote quality use of medicines in New Zealand

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 472, 2005-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite

A Perspective on New Zealand's Medicines Regulatory Environment

By Richardson R.   Shaw I.   Nolan S.  

International Journal of Pharmaceutical Medicine, Vol. 17, Iss. 1, 2003-01 ,pp. : 17-22

Adis International

Access to resources Recommend Favorite